Current applications and future perspective of CRISPR/Cas9 gene editing in cancer
2022 · Molecular Cancer · 414 citations
https://doi.org/10.1186/s12943-022-01518-8
Y
Yi-Min Zheng
Fudan University(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
26
Papers
1.3K
Citations
13
h-index
14
i10-index
Yi-Min Zheng is an academic researcher from Fudan University. The author has contributed to research in topics: Ferroptosis and cancer prognosis & interferon and immune responses & HIV Research and Treatment. The author has an h-index of 13, co-authored 23 publications.
ORCID: 0000-0001-9364-7636Papers by this author
worksAmplification of spatially isolated adenosine pathway by tumor–macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma
2021 · Journal of Hematology & Oncology · 162 citations
https://doi.org/10.1186/s13045-021-01207-x
Proteomic and metabolomic features in patients with HCC responding to lenvatinib and anti-PD1 therapy
2024 · Cell Reports · 17 citations
https://doi.org/10.1016/j.celrep.2024.113877
Cordycepin mediates pyroptosis in HCC through the upregulation of TXNIP and synergizes with anti–PD-L1 immunotherapy
2025 · Hepatology Communications · 6 citations
https://doi.org/10.1097/hc9.0000000000000633
KSR2-14–3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma
2022 · Biomarker Research · 5 citations
https://doi.org/10.1186/s40364-022-00361-9
Synthesis and in-vitro study of a novel ligustrazine diselenide as a potential chemotherapy drug for lung adenocarcinoma
2023 · Biomedicine & Pharmacotherapy · 5 citations
https://doi.org/10.1016/j.biopha.2023.114699
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat